Rigorous analysis of S2L-type phase solubility diagrams to obtain individual formation and solubility product constants of both SL-and S2L-type complexes

International Journal of Pharmaceutics

Volumn 151, Issue 1, 1997, Pages 109-119

  Zughul, M B ^a   Badwan, A A ^b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

Author keywords

Formation constants; Inclusion complexes; Phase solubility diagrams; S2L type complexes; Solubilization

Indexed keywords

ARTICLE; COMPUTER SIMULATION; MATHEMATICAL MODEL; MODEL; PHASE SEPARATION; PRIORITY JOURNAL; PROPRIOCEPTION; SOLUBILITY; SOLUBILIZATION;

EID: 0030943629     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)04901-6     Document Type: Article

References (21)

1. Abdul Rasool, A., Hussain, A.A. and Dittert, L.W., Solubility enhancement of some water-insoluble drugs in the presence of nicotinamide and related compounds. J. Pharm. Sci., 80 (1991) 387-393.
2. Connors, K.A. and Pendergast, D.D., Microscopic binding constants in cyclodextrin systems: complexation of α-cyclodextrin with sym-1,4-disubstituted benzenes. J. Am. Chem. Soc., 106 (1984) 7607-7614.
3. Connors, K.A., Lin, S. and Wong, A.B., Potentiometric study of molecular complexes of weak acids and bases applied to complexes of α-cyclodextrin with para-substituted benzoic acids. J. Pharm. Sci., 71 (1982) 217-222.
4. Connors, K.A., Paulson, A. and Toledo-Velasquez, D., Complexation of α-cyclodextrin with sym-4,4′-disubstituted biphenyls. J. Org. Chem., 53 (1988) 2023-2026.
5. Duchene, D. and Wouessidjewe, D., The current state of β-cyclodextrin in pharmaceutics. Acta Pharm. Technol., 36 (1990) 1-6.
6. Higuchi, T. and Connors, K.A., Phase solubility techniques. Adv. Anal. Chem. Instr., 4 (1965) 117-212.
7. Hoshino, T., Ishida, K., Irie, T., Hirayama, F. and Uekama, K., Reduction of photohemolytic activity of benoxaprofen by β-cyclodextrin complexations. J. Inclus. Phenom., 6 (1988) 415-423.
8. Krishnamoorthy, R. and Mitra, A.K., Complexation of weak acids and bases with cyclodextrins: effects of substrate ionization on the estimation and interpretation of association constants. Int. J. Pharm. Adv., 1 (1996) 329-343.
9. Liu, F., Kildsig, D.O. and Mitra, A.K., β-Cyclodextrin/steroid complexation: effect of steroid structure on association equilibria. Pharm. Res., 7 (1990) 869-873.
10. Marques, H.M.C., Hadgraft, J. and Kellaway, I.W., Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC. Int. J. Pharm., 63 (1990) 259-266.
11. Maurin, M., Rowe, S.M., Koval, C. and Hussain, M., Solubilization of nicardipine hydrochloride via complexation and salt formation. J. Pharm. Sci., 83 (1994) 1418-1420.
12. Menard, F.A., Dedhiya, M.G. and Rhodes C.T., Physicochemical aspects of the complexation of some drugs with cyclodextrins. Drug Dev. Ind. Pharm., 16 (1990) 91-113.
13. Muller, B.W. and Brauns, U., Solubilization of drugs by modified β-cyclodextrins. Int. J. Pharm., 26 (1985) 77-88.
14. Seo, H., Tsuruoka, M., Fujinaga, T., Otagiri, M. and Uekama, K., Enhancement of oral bioavailability of spironolactone by β-and γ-cyclodextrin complexations. Chem. Pharm. Bull., 31 (1983) 286-291.
15. Sideris, E.E., Valsami, G.N., Koupparis, M.A. and Macheras, P.E., Determination of association constants in cyclodextrin/drug complexation using the scatchard plot: application to β-cyclodextrin-anilinonaphthalenesulfonates. Pharm. Res., 9 (1992) 1568-1574
16. Streng, W.H., Hsi, S.K., Helms, P.E. and Tan, H.G.H., General treatment of pH-solubility profiles of weak acids and bases and the effects of different acids on the solubility of a weak base. J. Pharm. Sci., 73 (1984) 1679-1684.
17. Takahashi, T., Kagami, I., Kitamura, K., Nakanishi, Y. and Imasato, Y., Stabilization of AD-1590, a non-steroidal antiinflamatory agent in suppository bases by β-cyclodextrin complexation. Chem. Pharm. Bull., 34 (1986) 1770-1774.
18. Tong, W., Lach, J.L., Chin, T. and Guillory, J.K., Microcalorimetric investigation of the complexation between 2-hydroxypropyl-β-cyclodextrin and amine drugs with the diphenylmethyl functionality. J. Pharm. Biol. Anal., 9 (1991) 1139-1146.
19. Uekama, K., Ikeda, Y., Hirayama, M., Otagiri, M. and Shibata, M., Inclusion complexation of p-hydroxybenzoic acid esters with α-and β-cyclodextrins: dissolution behaviors and antimicrobial activities. Yakugaku Zasshi, 100 (1980) 994-1003.
20. Valsami, G.N., Macheras, P.E. and Koupparis, M., Binding studies of ions with cyclodextrins using ion-selective electrodes. J. Pharm. Sci., 79 (1990) 1087-1094.
21. Yusuff, N. and York, P., Spironolactone-cyclodextrin complexes: phase solubility and ultrafiltration studies. Int. J. Pharm., 73 (1991) 9-15.